Keros Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $115M | 2.5M | 45.70 |
| 2024-03-31 | $143M | 2.2M | 66.20 |
| 2023-09-30 | $60M | 1.9M | 31.88 |
| 2023-06-30 | $70M | 1.7M | 40.18 |
| 2023-03-31 | $72M | 1.7M | 42.70 |
| 2022-12-31 | $79M | 1.6M | 48.02 |
| 2022-06-30 | $39M | 1.4M | 27.58 |
| 2021-06-30 | $53M | 1.2M | 42.48 |
| 2021-03-31 | $75M | 1.2M | 61.55 |
| 2020-12-31 | $85M | 1.2M | 70.49 |
| 2020-09-30 | $25M | 655k | 38.46 |